Lomond Therapeutics Holdings, Inc. - Common Stock Institutional Ownership

Q: What is CUSIP 54173L101?

CUSIP 54173L101 is the security identifier used in SEC filing datasets for 54173L101 - Lomond Therapeutics Holdings, Inc. - Common Stock.

Q: Who owns 54173L101 - Lomond Therapeutics Holdings, Inc. - Common Stock based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 54173L101

13F Institutional Holders and Ownership History

Type / Class: Equity / Common Stock
Shares outstanding: 32,208,433

Investment Quick Answers

What is CUSIP 54173L101?
CUSIP 54173L101 identifies 54173L101 - Lomond Therapeutics Holdings, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Significant Owners of Lomond Therapeutics Holdings, Inc. - Common Stock based on Schedule 13D/G filings

Filer	Ownership	Nb Shares	Reporting Name	Report Period
Flynn James E	8.4%	2,692,625	Deerfield Mgmt, L.P.	30 Sep 2025
Yosemite Fund I, L.P.	8.4%	2,500,000	Yosemite Fund I, L.P.	24 Jan 2025
Qatar Investment Authority	7.8%	2,500,000	Qatar Investment Authority	24 Mar 2025
Tompkins Mark N.	4%	1,187,500	Mark N. Tompkins	31 Dec 2024
Jacobs Ian Seth	0.59%	175,000	Ian Jacobs	31 Dec 2024